Isracann Biosciences Inc.

VANCOUVER, A1 · CIK 0001726529 · Software

AI-native geographic information system (GIS) platform for conversational map building and spatial analysis

atlas.co →
Grants
—
No SBIR or STTR on record
Sector median: 0
Raised
$1.5M
4 Form D · Nov 2022
47 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 0

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$508,638
Private capital raisedForm D · SEC$549,928
Private capital raisedForm D · SEC$393,221
Private capital raisedForm D · SEC$3,737
Form D · SEC

Peer position

Software · 4096 companies · ranked on federal contract value
Software companies ranked by federal contract value
#CompanyContractsDisclosed equity
1550MVC Technologies Inc.—$3.7M
1551Advanced Filtration Technologies, Inc.—$60K
1552BlastPoint, Inc.—$21M
1553Isracann Biosciences Inc.—$1.5M
1554Atomontage Inc.—$3.6M
1555NEJI INC.—$850K
1556Murmur Labs, Inc.—$10M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 11 related persons
  • Desmond BalakrishnanDirector
  • Sean BromleyDirector
  • Matthew ChattertonExecutive Officer
  • Phil FloucaultDirector · Executive Officer
  • Arbel IritDirector
  • Charlie KiserExecutive Officer
  • Yana PopovaDirector · Executive Officer
  • Frederick StearmanDirector · Executive Officer
  • James ThompsonExecutive Officer
  • John VeltheerDirector
  • George VrabecDirector